Please login to the form below

Not currently logged in
Email:
Password:

PPMS

This page shows the latest PPMS news and features for those working in and with pharma, biotech and healthcare.

Roche’s Ocrevus is first primary progressive MS drug in EU

Roche’s Ocrevus is first primary progressive MS drug in EU

There are an estimated 96, 000 Europeans with PPMS, a highly-disabling early-onset form of the disease in which there is no relapsing/remitting stage. ... Nevertheless, the charity points out that the EU license means the drug can only be prescribed for

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • It's time to change the conversation

    Take Multiple Sclerosis (MS) for example. MS has four different disease manifestations: Relapsing Remitting (RRMS), Secondary Progressive (SPMS), Primary Progressive (PPMS) and Progressive Relapsing (PRMS).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics